Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0YB3X
|
||||
| Former ID |
DNC012403
|
||||
| Drug Name |
3-Chloro-N-(4-phenyl-thiazol-2-yl)-benzamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [526099] | ||
| Formula |
C16H11ClN2OS
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)C2=CSC(=N2)NC(=O)C3=CC(=CC=C3)Cl
|
||||
| InChI |
1S/C16H11ClN2OS/c17-13-8-4-7-12(9-13)15(20)19-16-18-14(10-21-16)11-5-2-1-3-6-11/h1-10H,(H,18,19,20)
|
||||
| InChIKey |
OHXHEHNTSIBWMV-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Adenosine A1 receptor | Target Info | Inhibitor | [526099] | |
| NetPath Pathway | TCR Signaling Pathway | ||||
| RANKL Signaling Pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.